Activated Abl kinase inhibits oncogenic transforming growth factor-β signaling and tumorigenesis in mammary tumors

Abl tyrosine kinases modulate cadherin-dependent adhesion upstream and downstream of Rho family GTPases

(2010) Nicole L. Zandy et al.   CELL CYCLE

Mechanics, malignancy, and metastasis: The force journey of a tumor cell

(2009) Sanjay Kumar et al.   CANCER AND METASTASIS REVIEWS

TGF-β-induced epithelial to mesenchymal transition

(2009) Jian Xu et al.   CELL RESEARCH

The TGF-β paradox in human cancer: an update

(2009) Maozhen Tian et al.   Future Oncology

A non-Smad mechanism of fibroblast activation by transforming growth factor-β via c-Abl and Egr-1: selective modulation by imatinib mesylate

(2009) S Bhattacharyya et al.   ONCOGENE

Imatinib mesylate (Gleevec(R)) in advanced breast cancer-expressing C-Kit or PDGFR- : clinical activity and biological correlations

(2008) M. Cristofanilli et al.   ANNALS OF ONCOLOGY

TGF-β1 induced MMP-9 expression in HNSCC cell lines via Smad/MLCK pathway

(2008) Sariya Nuchanardpanit Sinpitaksakul et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Altered TAB1:I B Kinase Interaction Promotes Transforming Growth Factor  -Mediated Nuclear Factor- B Activation during Breast Cancer Progression

(2008) J. R. Neil et al.   CANCER RESEARCH

Grb2 binding to Tyr284 in TβR-II is essential for mammary tumor growth and metastasis stimulated by TGF-β

(2008) Amy J. Galliher-Beckley et al.   CARCINOGENESIS

Fibulin-5 initiates epithelial-mesenchymal transition (EMT) and enhances EMT induced by TGF-  in mammary epithelial cells via a MMP-dependent mechanism

(2008) Y.-H. Lee et al.   CARCINOGENESIS

The Epithelial-Mesenchymal Transition Generates Cells with Properties of Stem Cells

(2008) Sendurai A. Mani et al.   CELL

MMP-13 is over-expressed in renal cell carcinoma bone metastasis and is induced by TGF-β1

(2008) Scott L. Kominsky et al.   CLINICAL & EXPERIMENTAL METASTASIS

Three-dimensional context regulation of metastasis

(2008) Janine T. Erler et al.   CLINICAL & EXPERIMENTAL METASTASIS

A Phase II Study of Imatinib Mesylate and Capecitabine in Metastatic Breast Cancer: Southwest Oncology Group Study 0338

(2008) Helen K. Chew et al.   Clinical Breast Cancer

Imatinib mesylate for the treatment of chronic myeloid leukemia

(2008) Simona Soverini et al.   Expert Review of Anticancer Therapy

Role of c-Abl Kinase in DNA Mismatch Repair-dependent G2Cell Cycle Checkpoint Arrest Responses

(2008) Mark W. Wagner et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

DNA Mismatch Repair-dependent Activation of c-Abl/p73α/GADD45α-mediated Apoptosis

(2008) Long Shan Li et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Activated c-Abl tyrosine kinase in malignant solid tumors

(2008) J Lin et al.   ONCOGENE

A Phase II Trial of Imatinib Mesylate in Patients With Metastatic Pancreatic Cancer

(2008) Mecide Gharibo et al.   PANCREAS